0 CHECKOUT

PRODUCT FILTERS

REGION

11
4
3
3
1

COUNTRY

3
1
1

CATEGORIES

  • 26
  • 12
  • 7
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

23
29
42
55

PUBLISHED

5
5
15
55

PRODUCT TYPE

36
12
4
2
1

Search for: "Acne Vulgaris"

55 Products

Acne Vulgaris-Pipeline Insights

Summary Acne Vulgaris- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Acne Vulgaris. The main objective of this report to track competitor pipeline molecules, related...

Published:  August 2015
Price:  From

Acne Vulgaris - Pipeline Review, H1 2015

Acne Vulgaris - Pipeline Review, H1 2015 Summary This, ‘Acne Vulgaris - Pipeline Review, H1 2015’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report provides comprehensive...

Published:  May 2015
Price:  From

Acne Vulgaris - Pipeline Review, H2 2014

Acne Vulgaris - Pipeline Review, H2 2014 Summary This, ‘Acne Vulgaris - Pipeline Review, H2 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report provides comprehensive...

Published:  September 2014
Price:  From

Acne Vulgaris - Pipeline Review, H1 2014

Acne Vulgaris - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acne Vulgaris - Pipeline Review, H1 2014’, provides an overview of the Acne Vulgaris’s therapeutic pipeline. This report...

Published:  March 2014
Price:  From

Acne Vulgaris - Pipeline Review, H2 2013

Acne Vulgaris - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  August 2013
Price:  From

Acne Vulgaris-API Insights

Summary Acne Vulgaris-API Insights, 2015 report provides Acne Vulgaris drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea...

Published:  August 2015
Price:  From

Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

“Acne Vulgaris-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015” Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acne Vulgaris....

Published:  August 2015
Price:  From

OpportunityAnalyzer: Acne Vulgaris - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Acne Vulgaris - Opportunity Analysis and Forecasts to 2018 Summary Despite its considerable patient population, the acne market has been overlooked and remained stagnant for the...

Published:  June 2014
Price:  From

Acne Vulgaris Global Clinical Trials Review, H2, 2013

Acne Vulgaris Global Clinical Trials Review, H2, 2013 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario....

Published:  September 2013
Price:  From

Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment

“ Acne Vulgaris- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014” provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication....

Published:  August 2015
Price:  From

Acne Vulgaris Global Clinical Trials Review, H2, 2012

Acne Vulgaris Global Clinical Trials Review, H2, 2012 Summary Our clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2012" provides data on the Acne Vulgaris clinical trial scenario....

Published:  September 2012
Price:  From

Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials

GBI Research, the leading business intelligence provider, has released its latest research ‘Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success...

Published:  January 2012
Price:  From

Acne Vulgaris - Pipeline Review, H1 2013

Acne Vulgaris – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

Published:  February 2013
Price:  From

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers

Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers Summary GBI Research’s report ‘Clinical Trial Recruitment in Dermatology...

Published:  October 2011
Price:  From

Acne Vulgaris - Pipeline Review, H2 2012

Acne Vulgaris – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H2 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

Published:  August 2012
Price:  From

Acne Vulgaris Global Clinical Trials Review, H2, 2011

Acne Vulgaris Global Clinical Trials Review, H2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2011" provides data on the Acne Vulgaris clinical...

Published:  November 2011
Price:  From

Acne Vulgaris Global Clinical Trials Review, Q2, 2011

Acne Vulgaris Global Clinical Trials Review, Q2, 2011 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, Q2, 2011" provides data on the Acne Vulgaris clinical...

Published:  June 2011
Price:  From

Acne Vulgaris - Pipeline Review, H1 2012

Acne Vulgaris – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Acne Vulgaris - Pipeline Review, H1 2012', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

Published:  February 2012
Price:  From

Acne Vulgaris Global Clinical Trials Review, Q4, 2010

Acne Vulgaris Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Acne Vulgari Global Clinical Trials Review, Q4, 2010" provides data on the Acne Vulgari clinical trial scenario....

Published:  December 2010
Price:  From

Acne Vulgaris - Pipeline Review, Q4 2010

Acne Vulgaris - Pipeline Review, Q4 2010 Summary Global Markets Direct’s, “Acne Vulgaris Pipeline Review, Q4 2010”, provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides...

Published:  December 2010
Price:  From
Loading Indicator

Our Clients

  • NBC Universal Inc.
  • Samsung Group Ltd.
  • E.ON SE
  • DHL International GmbH
  • University of Cambridge
  • Kone Oyj
  • BP Plc.